Press Releases

July 31, 2003 Lupin Q1 FY 2003-04 net profit up 38% at Rs 280.6 mn; sales up 23% at Rs 2,769 mn

July 28, 2003 Lupin receives USFDA approval for cefuroxime axetil tablets

May 20, 2003 Lupin FY2002-03 net sales up 19% at Rs 10.3 bn

April 17, 2003 Statement on media reports linking SARS outbreak with demand for Lupin’s ribavirin

February 24, 2003 Lupin receives USFDA approval for Cefixime Suspension

February 13, 2003 Lupin to set up new Lovastatin plant A move to consolidate presence in lifestyle drugs

January 28, 2003 Lupin Q3 sales up 19% at Rs. 2868 mn; net profit up 23% at Rs. 227mn

October 29, 2002 Lupin Q2 sales up 23% at Rs. 2,985 mn; profit before tax up 35% at Rs. 353 mn

July 24, 2002 Lupin Q1 FY03 sales at Rs 2514 million, up 8%; net up 26% at Rs 203 million